460 related articles for article (PubMed ID: 32579102)
1. Whole-genome sequencing analysis of multidrug-resistant
Tania T; Sudarmono P; Kusumawati RL; Rukmana A; Pratama WA; Regmi SM; Kaewprasert O; Chaiprasert A; Chongsuvivatwong V; Faksri K
J Med Microbiol; 2020 Jul; 69(7):1013-1019. PubMed ID: 32579102
[No Abstract] [Full Text] [Related]
2. Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Indonesia.
Chaidir L; Ruesen C; Dutilh BE; Ganiem AR; Andryani A; Apriani L; Huynen MA; Ruslami R; Hill PC; van Crevel R; Alisjahbana B
J Glob Antimicrob Resist; 2019 Mar; 16():170-177. PubMed ID: 30172045
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of whole genome sequencing versus phenotypic (MGIT) and commercial molecular tests for detection of drug-resistant Mycobacterium tuberculosis isolated from patients in Brazil and Mozambique.
Feliciano CS; Namburete EI; Rodrigues Plaça J; Peronni K; Dippenaar A; Warren RM; Silva WA; Bollela VR
Tuberculosis (Edinb); 2018 May; 110():59-67. PubMed ID: 29779775
[TBL] [Abstract][Full Text] [Related]
4. Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia.
Vīksna A; Sadovska D; Berge I; Bogdanova I; Vaivode A; Freimane L; Norvaiša I; Ozere I; Ranka R
BMC Infect Dis; 2023 Sep; 23(1):638. PubMed ID: 37770850
[TBL] [Abstract][Full Text] [Related]
5. Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol.
Al-Mutairi NM; Ahmad S; Mokaddas E
Microb Drug Resist; 2018 Sep; 24(7):923-931. PubMed ID: 29336677
[TBL] [Abstract][Full Text] [Related]
6. Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XDR-TB in Thailand.
Faksri K; Kaewprasert O; Ong RT; Suriyaphol P; Prammananan T; Teo YY; Srilohasin P; Chaiprasert A
Int J Antimicrob Agents; 2019 Aug; 54(2):109-116. PubMed ID: 30981926
[TBL] [Abstract][Full Text] [Related]
7. Whole-genome sequencing of presumptive MDR-TB isolates from a tertiary healthcare setting in Mumbai.
Zade A; Shah S; Hirani N; Kondabagil K; Joshi A; Chatterjee A
J Glob Antimicrob Resist; 2022 Dec; 31():256-262. PubMed ID: 36272707
[TBL] [Abstract][Full Text] [Related]
8. Genotypic drug resistance using whole-genome sequencing of Mycobacterium tuberculosis clinical isolates from North-western Tanzania.
Kidenya BR; Mshana SE; Fitzgerald DW; Ocheretina O
Tuberculosis (Edinb); 2018 Mar; 109():97-101. PubMed ID: 29559127
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Serial Multidrug-Resistant Tuberculosis Strains Causing Treatment Failure and Within-Host Evolution by Whole-Genome Sequencing.
Chen X; He G; Lin S; Wang S; Sun F; Chen J; Zhang W
mSphere; 2020 Dec; 5(6):. PubMed ID: 33361124
[TBL] [Abstract][Full Text] [Related]
10. Discordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence Country.
Ahmad S; Mokaddas E; Al-Mutairi N; Eldeen HS; Mohammadi S
PLoS One; 2016; 11(4):e0153563. PubMed ID: 27096759
[TBL] [Abstract][Full Text] [Related]
11. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
[TBL] [Abstract][Full Text] [Related]
12. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O;
Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia.
Lisdawati V; Puspandari N; Rif'ati L; Soekarno T; M M; K S; Ratnasari L; Izzatun N; Parwati I
BMC Infect Dis; 2015 Aug; 15():366. PubMed ID: 26297576
[TBL] [Abstract][Full Text] [Related]
14. Phylogenomic assessment of drug-resistant Mycobacterium tuberculosis strains from Beira, Mozambique.
Namburete EI; Dippenaar A; Conceição EC; Feliciano C; Nascimento MMPD; Peronni KC; Silva WA; Ferro JJ; Harrison LH; Warren RM; Bollela VR
Tuberculosis (Edinb); 2020 Mar; 121():101905. PubMed ID: 32063558
[TBL] [Abstract][Full Text] [Related]
15. Whole genome sequencing of clinical strains of Mycobacterium tuberculosis from Mumbai, India: A potential tool for determining drug-resistance and strain lineage.
Chatterjee A; Nilgiriwala K; Saranath D; Rodrigues C; Mistry N
Tuberculosis (Edinb); 2017 Dec; 107():63-72. PubMed ID: 29050774
[TBL] [Abstract][Full Text] [Related]
16. Whole-genome sequencing of clinical isolates from tuberculosis patients in India: real-world data indicates a high proportion of pre-XDR cases.
Bhanushali A; Atre S; Nair P; Thandaseery GA; Shah S; Kuruwa S; Zade A; Nikam C; Gomare M; Chatterjee A
Microbiol Spectr; 2024 May; 12(5):e0277023. PubMed ID: 38597637
[TBL] [Abstract][Full Text] [Related]
17. Utility of whole genome sequencing for multidrug resistant Mycobacterium tuberculosis isolates in a reference TB laboratory in New Zealand.
Basu I; Bower JE; Roberts SA; Henderson G; Aung HL; Cook G; Lowe O; Newton S
N Z Med J; 2018 Dec; 131(1487):15-22. PubMed ID: 30543607
[TBL] [Abstract][Full Text] [Related]
18. Diversified lineages and drug-resistance profiles of clinical isolates of
Noorizhab Fakhruzzaman MN; Abidin NZ; Aziz ZA; Lim WF; Richard JJ; Noorliza MN; Hani MH; Norhayati R; Zamzurina AB; Farida Zuraina MY; Hisyam MJ; Teh LK; Norazmi MN; Zaki MS
Int J Mycobacteriol; 2019; 8(4):320-328. PubMed ID: 31793500
[TBL] [Abstract][Full Text] [Related]
19. Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda.
Ssengooba W; Meehan CJ; Lukoye D; Kasule GW; Musisi K; Joloba ML; Cobelens FG; de Jong BC
Infect Genet Evol; 2016 Jun; 40():8-16. PubMed ID: 26917365
[TBL] [Abstract][Full Text] [Related]
20. What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis.
Heyckendorf J; Andres S; Köser CU; Olaru ID; Schön T; Sturegård E; Beckert P; Schleusener V; Kohl TA; Hillemann D; Moradigaravand D; Parkhill J; Peacock SJ; Niemann S; Lange C; Merker M
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
